Cargando…
FDX1-dependent and independent mechanisms of elesclomol-mediated intracellular copper delivery
Recent studies have uncovered the therapeutic potential of elesclomol (ES), a copper-ionophore, for copper deficiency disorders. However, we currently do not understand the mechanism by which copper brought into cells as ES–Cu(II) is released and delivered to cuproenzymes present in different subcel...
Autores principales: | Zulkifli, Mohammad, Spelbring, Amy N., Zhang, Yuteng, Soma, Shivatheja, Chen, Si, Li, Luxi, Le, Trung, Shanbhag, Vinit, Petris, Michael J., Chen, Tai-Yen, Ralle, Martina, Barondeau, David P., Gohil, Vishal M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10013847/ https://www.ncbi.nlm.nih.gov/pubmed/36848556 http://dx.doi.org/10.1073/pnas.2216722120 |
Ejemplares similares
-
Elesclomol restores mitochondrial function in genetic models of copper deficiency
por: Soma, Shivatheja, et al.
Publicado: (2018) -
Elesclomol elevates cellular and mitochondrial iron levels by delivering copper to the iron import machinery
por: Garza, Natalie M., et al.
Publicado: (2022) -
Metallothioneins regulate ATP7A trafficking and control cell viability during copper deficiency and excess
por: Gudekar, Nikita, et al.
Publicado: (2020) -
Oral Elesclomol Treatment Alleviates Copper Deficiency in Animal Models
por: Yuan, Sai, et al.
Publicado: (2022) -
Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy
por: Zheng, Peijie, et al.
Publicado: (2022)